, Tracking Stock Market Picks
Enter Symbol:
United Therapeutics Corporation (UTHR) [hlAlert]

up 382.28 %

United Therapeutics Corporation (UTHR) rated Buy with price target $90 by Auriga U.S.A

Posted on: Friday,  Apr 29, 2011  8:25 AM ET by Auriga U.S.A

Auriga U.S.A rated Buy United Therapeutics Corporation (NASDAQ: UTHR) on 04/29/2011. Previously Auriga U.S.A rated Buy United Therapeutics Corporation (NASDAQ: UTHR) on
05/05/2009., when the stock price was $33.23. Since then, United Therapeutics Corporation has gained 382.29% as of 01/27/2016's recent price of $160.24.
If you would have followed the previous Auriga U.S.A's recommendation on UTHR, you would have gained 382.28% of your investment in 2458 days.

UTD THERAPEUTIC is a biotechnology company focused on combating cardiovascular, inflammatory, and infectious diseases with unique therapeutic products. These products include pharmaceuticals, arginine products and telemedicine services.

Auriga is committed to providing our clients with market information flow, investment ideas and access to industry experts. We strive to provide value through unique industry knowledge. Our growing research practice is being built with domain experts who have a strong reputation amongst institutional investors. Auriga’s research analysts have also been recognized by numerous industry publications including, The Wall Street Journal and Bloomberg. Our bottom-up fundamental approach is data point driven with a primary focus on growth sectors within the technology and healthcare verticals.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
4/29/2011 8:25 AM Buy
67.18 90.00
as of 12/30/2011
1 Week up  1.48 %
1 Month up  15.49 %
3 Months up  26.03 %
1 YTD down  -25.26 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/16/2011 1:33 PM Buy
67.28 90.00
10/29/2010 8:25 AM Buy
60.00 72.00
7/20/2009 10:25 AM Buy
42.46 54.00
5/5/2009 8:25 AM Buy
33.23 41.50

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy